國內民眾健康意識提升，許多營養保健品越來越多元化，如何保護這些對人體具有營養保健之物質，免受外在環境破壞，將產品膠囊化便是其中方式之一。本研究使用疏水性之聚二甲基矽氧烷（polydimethylsiloxane, PDMS）搭配玻璃基板製作微流體通道，以2%褐藻酸鈉溶液作為包覆水相，含醋酸鈣的植物油溶液作為核芯油，來製備包覆牛樟芝萃取物之微膠囊。研究結果顯示，將PDMS通道表面修飾為親水性後，適當調整水相及油相之流速可穩定地形成膠囊。其中以2%褐藻酸鈉與含1.5%、2.0%、2.5%醋酸鈣之植物油溶液搭配所形成之微膠囊較不易破損，且2%褐藻酸鈉和2.5%醋酸鈣所製備之微膠囊最為穩定，其平均粒徑分別為149.40 ±1.67 μm及 172.75±1.75 μm。2%褐藻酸鈉與含2.0%、2.5%醋酸鈣及牛樟芝萃取物之植物油溶液所製備之微膠囊，經模擬胃液處理一小時後，其耐受（酸）性程度較高，分別具72.97%與78.20%之耐受（酸）性。未來可利用此方式，製備水包覆油（o/w）或油包覆水（w/o）之微粒，來包覆藥物或生物細胞等，期望在生醫及藥物釋放研究領域上有所應用與發展。

In this study, we described the process of formation of Taiwanofungus camphorates microcapsules by microfluidic system of polydimethylsiloxane (PDMS). To the side channels we administered the canola oil with addition of calcium acetate. The discontinuous phase was an aqueous solution of alginate. The result demonstrated that modified the surface chemistry of the channels to render it hydrophile which changing the rates of flow of the side channels and of the discontinuous phase that allowed to formation of Ca-alginate microbeads. To formulate alginate microbeads we used aqueous solution of 2.0%（w/w）alginate and a range of concentrations of calcium acetate in oil：between 0.5%, 1.0%, 1.5%, 2.0% and 2.5%（w/w）. The mean diameter was 149.40 μm and 172.75 μm of 2.0% and 2.5%（w/w）calcium acetate of Ca-alginate microbeads. And we found the microcapsules of 2.0% and 2.5%（w/w）calcium acetate of Ca-alginate microbeads in hydrochloric acid solution（pH 1.5）for one hour, the tolerance level was 72.97% and 78.20%. However, the formulation of Ca-alginate microcapsules, using a microfluidic chip was simple and fast. The use of microfluidics to control the delivery of ions of encapsulation of microbeads and for tuning the rate of release from Ca-alginate.

謝誌
中文摘要................................................I
英文摘要................................................II
總目錄..................................................III
表目錄..................................................VI
圖目錄..................................................VII
第一章 前言..............................................1
1.1 牛樟芝簡介.........................................1
1.1.1 牛樟芝成分.....................................2
1.1.2 牛樟芝生理活性..................................7
1.1.2.1 護肝作用...................................7
1.1.2.2 抗氧化能力.................................7
1.1.2.3 抗病毒能力.................................8
1.1.2.4 減輕酒精誘發之肝損傷.........................8
1.1.2.5 抑制腫瘤細胞生長之研究.......................8
1.1.2.6 毒性及安全性研究............................9
1.2 微膠囊............................................10
1.2.1 微膠囊及其特點.................................10
1.2.2 微膠囊的包覆壁材................................11
1.2.2.1 幾丁聚糖..................................11
1.2.2.2 阿拉伯膠..................................11
1.2.2.3 褐藻酸鈉..................................11
1.2.3 微膠囊的製備方式................................12
1.2.3.1 噴霧乾燥法.................................12
1.2.3.2 相分離法..................................13
1.2.3.3 離心擠壓製程...............................13
1.2.3.4 乳化硬化製程...............................14
1.2.3.5 平盤包覆..................................15
1.3 生物晶片..........................................16
1.3.1 微陣列晶片……….................................16
1.3.2 微流體晶片……….................................16
1.3.3 生物晶片的應用…................................17
1.4 研究動機與目的.....................................18
第二章 材料與方法........................................19
2.1 實驗架構與設計.....................................19
2.2 實驗材料..........................................20
2.2.1 藥品.........................................20
2.2.2 儀器設備......................................20
2.3 微流體通道製作.....................................22
2.3.1 光罩設計與製作.................................22
2.3.2 玻片清洗......................................23
2.3.3 微影製程......................................23
2.3.3.1 負光阻塗佈................................23
2.3.3.2 軟烤.....................................25
2.3.3.3 曝光.....................................25
2.3.3.4 曝後烤...................................25
2.3.3.5 顯影.....................................26
2.3.3.6 硬烤.....................................26
2.3.4 PDMS翻模.....................................26
2.3.5 剝模.........................................27
2.3.6 PDMS表面修飾..................................27
2.3.7 氧電漿黏合....................................27
2.4 微膠囊製備........................................28
2.4.1 牛樟芝萃取液製備...............................28
2.4.2 褐藻酸鈉溶液配製...............................28
2.4.3 醋酸鈣植物油溶液配製............................29
2.4.4 牛樟芝萃取液膠囊化..............................29
2.5 微膠囊分析........................................30
2.5.1 粒徑大小及粒徑分佈.............................30
2.5.2 耐受（酸）性測試...............................30
2.5.3 釋放之測試....................................31
2.5.4 粗三帖含量測定.................................31
第三章 結果與討論........................................32
3.1 PDMS微流體通道實際尺寸.............................32
3.2 利用微流體通道製備膠囊..............................33
3.3 不同醋酸鈣濃度製備微膠囊之情形.......................38
3.4 以含不同濃度醋酸鈣的植物油與2%褐藻酸鈉溶液在微流體系
統中形成的微膠囊粒徑大小及分佈........................42
3.5 耐受（酸）性測試..................................56
3.6 釋放率測試.......................................56
第四章 結論與展望.......................................61
參考文獻...............................................62

﹝1﹞臧穆、蘇慶華。 1990。我國台灣產靈芝屬-新種-樟芝。雲南植物研究 12：395-396.
﹝2﹞Chang T.T. and Chou W.N. 1995. Antrodia cinnamomea sp. nov. on Cinnamomum kanehirai in Taiwan. Mycological Research 99(6):756-758.
﹝3﹞Wu S.H., Ryvarden L. and Chang T.T. 1997. Antrodia camphorata ("niu-chang-chih"), new combination of a medicinal fungus in Taiwan. Botanical Bulletin of Academia Sinica 38(4):273-275.
﹝4﹞Wu S.H., Yu Z.H., Dai Y.C., Chen C.T., Su C.H., Chen L.C., Hsu W.C. and Hwang G.Y. 2004. Taiwanofungus, a polypore new genus. Fung Science 19(3-4):109-116.
﹝5﹞Geethangili M. and Tzeng Y.M. 2011. Review of pharmacological effects of Antrodia camphorata and its bioactive compounds. Evidence-Based Complementary and Alternative Medicine 2011:1-17.
﹝6﹞Hsiao G., Shen M.Y., Lin K.H., Lan M.H., Wu L.Y., Chou D.S., Lin C.H., Su C.H. and Sheu J.R. 2003. Antioxidative and hepatoprotective effects of Antrodia camphorata extract. Journal of Agricultural and Food Chemistry 51(11):3302-3308.
﹝7﹞Hseu Y.C., Chen S.C., Yech Y.J., Wang L. and Yang H.L. 2008. Antioxidant activity of Antrodia camphorata on free radical-induced endothelial cell damage. Journal of Ethnopharmacology 118(2):237-245.
﹝8﹞Lee I.H., Huang R.L., Chen C.T., Chen H.C., Hsu W.C. and Lu M.K. 2002. Antrodia camphorate polysaccharides exhibit anti-hepatitis B virus effects. FEMS Microbiology Letters 209:63-67.
﹝9﹞Huang C.H., Chang Y.Y., Liu C.W., Kang W.Y., Lin Y.L., Chang H.C. and Chen Y.C. 2010. Fruiting body of Niuchangchih (Antrodia camphorata) protects livers against chronic alcohol consumption damage. Journal of Agricultural and Food Chemistry 58(6):3859-3866.
﹝10﹞Lien H.M., Kuo P.T., Huang C.L., Kao J.Y., Lin H., Yang D.Y. and Lai Y.Y. 2011. Study of the anti-proliferative activity of 5-substituted 4,7-dimethoxy-1,3-benzodioxole derivatives of SY-1 from Antrodia camphorata on human COLO 205 colon cancer cells. Evidence-Based Complementary and Alternative Medicine 2011:1-8.
﹝11﹞Chen T.I, Chen C.C., Lin T.W., Tsai Y.T. and Nam M.K. 2011. A 90-day subchronic toxicological assessment of Antrodia cinnamomea in Sprague–Dawley rats. Food and Chemical Toxicology 49(2):429-433.
﹝12﹞Nazzaro F., Orlando P., Fratianni F. and Coppola R. 2012. Microencapsulation in food science and biotechnology. Current Opinion in Biotechnology 23(2):182-186.
﹝13﹞Krishana S., Bhosale R. and Singhal R.S. 2005. Microencapsulation of cardamom oleoresin:evaluation of blends of gum arabic, maltodextrin and a modified starch as well materials. Carbohydrate Polymers 61(1):95-102.
﹝14﹞Bustos R., Romo L., Yanez K., Diaz G. and Romo C. 2003. Oxidative stability of carotenoid pigments and polyunsaturated fatty acids in microparticulate diets containing krill oil for nutrition of marine fish larvae. Journal of Food Engineering 56(2-3):289-293.
﹝15﹞Jafari S.M., Beheshti P. and Assadpoor E. 2012. Rheological behavior and stability of D-limonene emulsions made by a novel hydrocolloid (Angum gum) compared with Arabic gum. Journal of Food Engineering 109(1):1-8.
﹝16﹞Gharibzahedi S.M.T., Mousavi S.M., Hamedi M., Khodaiyan F. and Razavi S.H. 2012. Development of an optimal formulation for oxidative stability of walnut-beverage mulsions based on gum arabic and xanthan gum using response surface methodology. Carbohydrate Polymers 87(2): 1611-1619.
﹝17﹞Zhang K., Zhang H.M., Hu X.C., Bao S.S. and Huang H. 2012. Synthesis and release studies of microalgal oil-containing microcapsules prepared by complex coacervation. Colloids and Surfaces B: Biointerfaces 89(1):61-66.
﹝18﹞Sogani M., Mathur N., Bhatnagar P. and Sharma P. 2012. Biotransformation of amide using Bacillus sp.：isolation strategy, strain characteristics and enzyme immobilization. International Journal of Environmental Science and Technology 9(1):119-127.

﹝19﹞Chen S., Zhao Q., Ferguson L.R., Shu Q., Weir I. and Garg S. 2012. Development of a novel probiotic delivery system based on microencapsulation with protectants. Applied Microbiology and Biotechnology 93(4):1447-1457.
﹝20﹞Kalyanasundaram S., Feinstein S., Nicholson J.P., Leong K.W. and Garver R.I. 1999. Coacervate microspheres as carriers of recombinant adenoviruses. Cancer Gene Therapy 6(2):107-112.
﹝21﹞Benchabane S., Subirade M. and Vandenberg G.W. 2007. Production of BSA-loaded alginate microcapsules: influence of spray dryer parameters on the microcapsule characteristics and BSA release. Journal of Microencapsulation 24(7):647-658.
﹝22﹞Lazko J., Popineau Y. and Legrand J. 2004. Soy glycinin microcapsules by simple coacervation method. Colloids and Surfaces B-Biointerfaces
37(1-2):1-8.
﹝23﹞Mohanty B. and Bohidar H.B. 2003. Systematic of alcohol-induced simple coacervation in aqueous gelatin solutions. Biomacromolecules 4(4):1080-1086.
﹝24﹞Lam P.L., Yuen M.C.W., Kan C.W., Wong R.S.M., Cheng G.Y.M., Lam K.H., Gambari R., Kok S.H.L. and Chui C.H. 2012. Development of calendula oil/chitosan microcapsules and their biological safety evaluation. Australian Journal of Chemistry 65(1):72-80.
﹝25﹞Cheng S.Y., Yuen C.W.M., Kan C.W., Cheuk K.K.L., Chui C.H. and Lam K.H. 2009. Cosmetic textiles with biological benefits: Gelatin microcapsules containing Vitamin C. International Journal of Molecular Medicine 24(4):411-419.
﹝26﹞Singh D., Febbo P.G., Ross K., Jackson D.G., Manola J., Ladd C., Tamayo P., Renshaw A.A., D`A mico A.V., Richie J.P., Lander E.S., Loda M., Kantoff P.W., Golub T.R. and Sellers W.R. 2002. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1(2):2003-2009.
﹝27﹞Chang C.L., Leong J.C., Hong T.F., Wang Y.N. and Fu L.M. 2011. Experimental and Numerical Analysis of High-Resolution Injection Technique for Capillary Electrophoresis Microchip. International Journal of Molecular Sciences 12(6): 3594-3605.
﹝28﹞Nie Z., Xu S., Seo M., Lewis P.C. and Kumacheva E. 2005. Polymer particles with various shapes and morphologies produced in continuous microfluidic reactors. Journal of The American Chemical 127(22):8058-
8063.
﹝29﹞Liu K., Ding H.J., Liu J., Chen Y. and Zhao X.Z. 2006. Shape-Controlled Production of Biodegradable Calcium Alginate Gel Microparticles Using a Novel Microfluidic Device. Langmuir 22(22):9453-9457.
﹝30﹞Chang C.L., Leong J.C., Hong T.F., Wang Y.N. and Fu L.M. 2011. Experimental and numerical analysis of high-resolution injection technique for capillary electrophoresis microchip. International Journal of Molecular Sciences 12(6):3594-3605.
﹝31﹞Ogończyk D., Siek M. and Garstecki P. 2011. Microfluidic formulation of pectin microbeads for encapsulation and controlled release of nanoparticles. Biomicrofluidics 5(1):013405-12
﹝32﹞Yang Z.Q., Song B.Z., Li Q.X., Fan H.L. and Fan O.Y. 2004. Preparation of microspheres with microballoons inside for floating drug-delivery systems. Journal of Applied Polymer Science 94(1):197-202.
﹝33﹞Su R., Zhu X.L., Fan D.D., Mi Y., Yang C.Y. and Jia X. 2011. Encapsulation of probiotic Bifidobacterium longum BIOMA 5920 with alginate-human-like collagen and evaluation of survival in simulated gastrointestinal conditions. International Journal of Biological Macromolecules 49:979-984.
﹝34﹞Fan J.P. and He C.H. 2006. Simultaneous quantification of three major bioactive triterpene acid in the leaves of Diospyros kaki by high-performance liquid chromatography method. Journal of Pharmaceutical and Biomedical Analysis 41(3):950-956.
﹝35﹞Zhou J.W., Ellis A.V. and Voelcker N.H. 2010. Recent developments in PDMS surface modification for microfluidic devices. Electrophoresis 31(1): 2-16.
﹝36﹞Zhou J.W., Khodakov D.A., Ellis A.V. and Voelcker N.H. 2012. Surface modification for PDMS-based microfluidic devices. Electrophoresis 33(1)89-104.
﹝37﹞Hwang S., Choi C.H. and Lee C.S. 2012. Regioselective surface modification of PDMS microfluidic device for the generation of monodisperse double emulsions. Macromolecular Research 20(4):422-428.
﹝38﹞Jokinen V., Suvanto P., Franssila S. 2012. Oxygen and nitrogen plasma hydrophilization and hydrophobic recovery of polymers. Biomicrofluidics 6(1):061501-10.
﹝39﹞Parvin A., Mirzadeh H., Khorasani M. T. 2008. Physicochemical and biological evaluation of plasma-induced graft polymerization of acrylamide onto polydimethylsiloxane. Journal of Applied Polymer Science 107(4):2343-2349.
﹝40﹞Ebara M., Hoffman J.M., Stayton P.S., Hoffman A.S. 2007. Surface modification of microfluidic channels by UV-mediated graft polymerization of non-fouling and‘smart’polymers. Radiation Physics and Chemistry 76(8-9):1409-1413.
﹝41﹞Yeh C.H., Chen Y.C. and Lin Y.C. 2011. Generation of droplets with different concentrations using gradient-microfluidic droplet generator. Microfluidics and Nanofluidics 11(3):245-253.
﹝42﹞Saeki D., Sugiura S., Kanamori T., Sato S. And Ichikawa S. 2010. Formation of mondisperse calcium alginate microbeads by rupture of water-in-oil-in-water droplets with an ultra-thin oil phase layer. Lab on a Chip 10(17):2292-2295.
﹝43﹞Rosas-Ledesma P., Leon-Rubio J.M., Alarcon F.J., Morinigo M.A., Balebona M.C. 2012. Calcium alginate capsules for oral administration of fish probiotic bacteria: assessment of optimal conditions for encapsulation. Aquaculture Research 43(1):106-116.
﹝44﹞Chang C.P. and Dobashi T. 2003. Preparation of alginate complex capsules containing eucalyptus essential oil and its controlled release. Colloids and Surfaces B: Biointerfacess 32:257-262.
﹝45﹞Wu Z.S., Zhao Y.F., Kaleem I. and Li C. 2011. Preparation of calcium-alginate microcapsuled microbial fertilizer coating Klebsiella oxytoca Rs-5 and its performance under salinity stress. European Journal of Soli Biology 47(2):152-159.
﹝46﹞Yotsuyanagi T., Ohkubo T., Ohhashi T. and Ikeda K. 1987. Calcium-induced gelation of alginic acid and pH-sensitive reswelling of dried gels. Chemical & pharmaceutical bulletin 35(4):1555-1563.
﹝47﹞Li Y., Kong M., Feng C., Liu W.F., Liu Y., Cheng X.J. and Chen X.G. 2012. Preparation and property of layer-by-layer alginate hydrogel beads based on multi-phase emulsion technique. Journal of Sol-Gel Science and Technology 62(2):217-226.
﹝48﹞Lee B.J. and Min G.H. 1996. Oral controlled release of melatonin using polymer-reinforced and coated alginate beads. International Journal of Pharmaceutics 144(1):37-46.